Peptidomimetic Probes and Molecular Modeling Suggest That Alzheimer's γ-Secretase Is an Intramembrane-Cleaving Aspartyl Protease
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The amyloid beta-protein (Abeta), implicated in the pathogenesis of Alzheimer's disease (AD), is a proteolytic metabolite generated by the sequential action of beta- and gamma-secretases on the amyloid precursor protein (APP). The two main forms of Abeta are 40- and 42-amino acid C-terminal variants, Abeta40 and Abeta42. We recently described a difluoro ketone peptidomimetic (1) that blocks Abeta production at the gamma-secretase level [Wolfe, M. S., et al. (1998) J. Med. Chem. 41, 6-9]. Although designed to inhibit Abeta42 production, 1 also effectively blocked Abeta40 formation. Various amino acid changes in 1 still resulted in inhibition of Abeta40 and Abeta42 production, suggesting relatively loose sequence specificity by gamma-secretase. The alcohol counterparts of selected difluoro ketones also lowered Abeta levels, indicating that the ketone carbonyl is not essential for activity and suggesting that these compounds inhibit an aspartyl protease. Selected compounds inhibited the aspartyl protease cathepsin D but not the cysteine protease calpain, corroborating previous suggestions that gamma-secretase is an aspartyl protease with some properties similar to those of cathepsin D. Also, since the gamma-secretase cleavage sites on APP are within the transmembrane region, we consider the hypothesis that this region binds to gamma-secretase as an alpha-helix and discuss the implications of this model for the mechanism of certain forms of hereditary AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [16]
Citations
Cites
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's Disease
Selkoe, D. J. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002105 · Cited by 747
Self-citationRawson, R. B., Zelenski, N. G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M. T., Chang, T. Y., Brown, M. S., & Goldstein, J. L. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80006-4 · Cited by 429
Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42
Wild-Bode, C., Yamazaki, T., Capell, A., Leimer, U., Steiner, H., Ihara, Y., & Haass, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16085 · Cited by 303
Leonhard, K., Herrmann, J. M., Stuart, R. A., Mannhaupt, G., Neupert, W., & Langer, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00796.x · Cited by 286
A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity
Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O., & Selkoe, D. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970621b · Cited by 215
Self-citationInhibition and catalytic mechanism of HIV-1 aspartic protease
Silva, A. M., Cachau, R. E., Sham, H. L., & Erickson, J. W. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0026 · Cited by 178
Klafki, H.-W., Abramowski, D., Swoboda, R., Paganetti, P. A., & Staufenbiel, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28655 · Cited by 159
Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., & Krafft, G. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32325-6 · Cited by 129
Research works printed but not linked: 36
- Tomita T., 1998, Neuroreport 9, 911−3
- Ross S. L., 1998, J. Biol. Chem., 273
- Selkoe D. J., 1997, Science 275, 630−1
- Hardy, 2095, J. (1997)
- Roher A. E., 1993, Proc. Natl. Acad. Sci. U.S.A. 90, 10836−40
- Jarrett J. T., 1993, Biochemistry 32, 4693−7
- Selkoe D. J., 1998, Abstract 8.3.
- Fehrentz J.-A., 1983, Synthesis, 676−8
- Xia W., 1997, J. Biol. Chem., 272
- Citron M., 1996, Proc. Natl. Acad. Sci. U.S.A. 93, 13170−5
- Johnson-Wood K., 1997, Proc. Natl. Acad. Sci. U.S.A. 94, 1550−5
- Seubert P., 1992, Nature 359, 325−7
- Buroker-Kilgore M., 1993, Anal. Biochem. 208, 387−92
- Weidemann A., 1989, Cell 57, 115−26
- Cook D. G., 1997, 3, 1021−3
- Hartmann T., 1997, 3, 1016−20
- Hardy J., 1997, Trends Neurosci. 20, 154−9
- Sakai J., 1996, Cell 85, 1037−46
- Schroeter E. H., 1998, Nature 393, 382−6
- Higaki J., 1995, Neuron 14, 651−9
- Wang K. K., 1990, Trends Pharmacol. Sci. 11, 139−42
- Mellgren R. L., 1997, Biochem. Biophys. Res. Commun. 236, 555−8
- Evin G., 1995, Biochemistry 34, 14185−92
- Doherty A. M., 1992, J. Med. Chem., 35, 14
- Maruyama K., 1996, Biochem. Biophys. Res. Commun. 227, 730−5
- Lichtenthaler S. F., 1997, Biochemistry 36, 15396−403
- Yamazaki T., 1997, Biochemistry 36, 8377−83
- Haass C., 1992, Nature 357, 500−3
- Parris K. D., 1992, Biochemistry 31, 8125−41
- James M. N., 1992, Biochemistry 31, 3872−86
- Veerapandian B., 1992, Protein Sci. 1, 322−8
- Takahashi L. H., 1989, J. Am. Chem. Soc., 111
- Duncan E. A., 1998, J. Biol. Chem., 273
- Walz T., 1997, Nature 387, 624−7
- Cheng A., 1997, Nature 387, 627−30
- Wolfe M. S., 1999, Nature (in press)
Cited by
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Self-citationOsteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,455
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
Self-citationWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Self-citationNotch Signaling: From the Outside In
Mumm, J. S., & Kopan, R. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9960 · Cited by 975
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
“Our conclusion that γ-secretase is an aspartyl protease agrees with that of a previous study showing that other aspartyl protease transition state analogues inhibit γ-secretase activity in cell”
ResultA Ligand-Induced Extracellular Cleavage Regulates γ-Secretase-like Proteolytic Activation of Notch1
Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., Ray, W. J., & Kopan, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80416-5 · Cited by 853
γ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Self-citationIntegration of Notch and Wnt signaling in hematopoietic stem cell maintenance
Duncan, A. W., Rattis, F. M., DiMascio, L. N., Congdon, K. L., Pazianos, G., Zhao, C., Yoon, K., Cook, J. M., Willert, K., Gaiano, N., et al. (2005) · Nature Immunology · doi:10.1038/ni1164 · Cited by 771
Butler, J. M., Nolan, D. J., Vertes, E. L., Varnum-Finney, B., Kobayashi, H., Hooper, A. T., Seandel, M., Shido, K., White, I. A., Kobayashi, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.001 · Cited by 688
“We also evaluated the role of Notch activation in expansion of LT-HSCs, by a g-secre- tase inhibitor (Wolfe et al., 1999).”
BackgroundMethodNotch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., Sriuranpong, V., Iso, T., Meszoely, I. M., Wolfe, M. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00140-5 · Cited by 643
Self-citationProteolytic processing and cell biological functions of the amyloid precursor protein
De Strooper, B., & Annaert, W. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1857 · Cited by 631
Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
Li, Y.-M., Lai, M.-T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X.-P., Yin, K.-C., Shafer, J. A., & Gardell, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110126897 · Cited by 525
Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
Esler, W. P., Kimberly, W. T., Ostaszewski, B. L., Diehl, T. S., Moore, C. L., Tsai, J.-Y., Rahmati, T., Xia, W., Selkoe, D. J., & Wolfe, M. S. (2000) · Nature Cell Biology · doi:10.1038/35017062 · Cited by 517
Self-citationRegulation of APP cleavage by α‐, β‐ and γ‐secretases
Nunan, J., & Small, D. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02076-7 · Cited by 512
Geling, A., Steiner, H., Willem, M., Bally‐Cuif, L., & Haass, C. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf124 · Cited by 497
“Along this line, Hadland et al. (2001) recently demonstrated that a distinct γ-secretase inhibitor (Cpd.11) (Wolfe et al., 1999b) added to fetal organ cultures represses thymocyte development, probably by reducing Notch signaling.”
BackgroundInfluentialA Portrait of Alzheimer Secretases--New Features and Familiar Faces
Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493
Self-citationShen, J., & Kelleher, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608332104 · Cited by 485
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
“…in APP near the -secretase site still allow A production in transfected cells (Maruyama et al., 1996; Tischer and Cordell, 1996; Lichtenthaler et al., 1997, 1999; Wolfe et al., 1999a–c) and seem to be a multiprotein complex, making its identification through expression cloning unlikely to succeed.”
BackgroundPresenilins and -Secretase: Structure, Function, and Role in Alzheimer Disease
De Strooper, B., Iwatsubo, T., & Wolfe, M. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006304 · Cited by 468
Self-citationKimberly, W. T., Zheng, J. B., Guénette, S. Y., & Selkoe, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100447200 · Cited by 444
Self-citationNEURODEGENERATIVE DISEASES: New Concepts of Pathogenesis and Their Therapeutic Implications
Skovronsky, D. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100113 · Cited by 425
The amyloid cascade hypothesis: are we poised for success or failure?
Karran, E., & De Strooper, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13632 · Cited by 402
The Presenilins in Alzheimer's Disease--Proteolysis Holds the Key
Haass, C., & Strooper, B. D. (1999) · Science · doi:10.1126/science.286.5441.916 · Cited by 388
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00047 · Cited by 208
Self-citationStructure and Mechanism of the Pepsin-Like Family of Aspartic Peptidases
Dunn, B. M. (2002) · Chemical Reviews · doi:10.1021/cr010167q · Cited by 372
Intramembrane Proteolysis: Theme and Variations
Wolfe, M. S., & Kopan, R. (2004) · Science · doi:10.1126/science.1096187 · Cited by 332
Self-citationBenjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009899200 · Cited by 301
Deciphering the Genetic Basis of Alzheimer's Disease
Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 294
Self-citationCell Surface Presenilin-1 Participates in the γ-Secretase-like Proteolysis of Notch
Ray, W. J., Yao, M., Mumm, J., Schroeter, E. H., Saftig, P., Wolfe, M., Selkoe, D. J., Kopan, R., & Goate, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36801 · Cited by 266
Self-citationKimberly, W. T., Xia, W., Rahmati, T., Wolfe, M. S., & Selkoe, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3173 · Cited by 253
Self-citationMaturation and Pro-peptide Cleavage of β-Secretase
Capell, A., Steiner, H., Willem, M., Kaiser, H., Meyer, C., Walter, J., Lammich, S., Multhaup, G., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003202200 · Cited by 205
A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development
Hadland, B. K., Huppert, S. S., Kanungo, J., Xue, Y., Jiang, R., Gridley, T., Conlon, R. A., Cheng, A. M., Kopan, R., & Longmore, G. D. (2004) · Blood · doi:10.1182/blood-2004-03-1224 · Cited by 240
Edbauer, D., Winkler, E., Haass, C., & Steiner, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132277899 · Cited by 225
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
A common enzyme connects Notch signaling and Alzheimer's disease
Kopan, R., & Goate, A. (2000) · Genes & Development · doi:10.1101/gad.836900 · Cited by 217
“Mutation of either of two aspartyl residues, predicted to be embedded in TM domains 6 and 7 based on the model proposed by Li and Greenwald (1996), inhibits endoproteolysis and leads to a loss of PS GENES & DEVELOPMENT 2801 function (Ray et al. 1999a; Steiner et al. 1999; Wolfe et al. 1999c).”
BackgroundInfluentialPresenilin, Notch, and the genesis and treatment of Alzheimer's disease
Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211352598 · Cited by 203
Self-citationSchroeter, E. H., Ilagan, M. X. G., Brunkan, A. L., Hecimovic, S., Li, Y.-M., Xu, M., Lewis, H. D., Saxena, M. T., De Strooper, B., Coonrod, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735338100 · Cited by 197
Self-citationWolfe, M. S. (2007) · EMBO reports · doi:10.1038/sj.embor.7400896 · Cited by 192
“Parallel studies revealed that peptide-substrate mimics with classical aspartyl protease-inhibitory motifs could inhibit γ-secretase, suggesting that the enzyme belongs to this category of proteases (Wolfe et al, 1999a).”
BackgroundSelf-citationTherapeutic strategies for Alzheimer's disease
Wolfe, M. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd938 · Cited by 190
Self-citationThe initial substrate-binding site of γ-secretase is located on presenilin near the active site
Kornilova, A. Y., Bihel, F., Das, C., & Wolfe, M. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407640102 · Cited by 188
Self-citationγ-Secretase inhibitors repress thymocyte development
Hadland, B. K., Manley, N. R., Su, D.-M., Longmore, G. D., Moore, C. L., Wolfe, M. S., Schroeter, E. H., & Kopan, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131202798 · Cited by 187
Self-citationAnnaert, W. G., Esselens, C., Baert, V., Boeve, C., Snellings, G., Cupers, P., Craessaerts, K., & De Strooper, B. (2001) · Neuron · doi:10.1016/s0896-6273(01)00512-8 · Cited by 184
Mann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64688-3 · Cited by 182
Murine Notch Homologs (N1–4) Undergo Presenilin-dependent Proteolysis
Saxena, M. T., Schroeter, E. H., Mumm, J. S., & Kopan, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107234200 · Cited by 175
Identification of a novel family of presenilin homologues
Ponting, C. P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1037 · Cited by 174
Bayer, T. A., Wirths, O., Majtényi, K., Hartmann, T., Multhaup, G., Beyreuther, K., & Czech, C. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00376.x · Cited by 173
Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.005 · Cited by 165
“, 1998), and others that presenilin is itself a γ-secretase (Wolfe et al., 1999).”
BackgroundResultChojnacki, A., Shimazaki, T., Gregg, C., Weinmaster, G., & Weiss, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01730.2003 · Cited by 166
“, 1999) and can be blocked by the peptidomimetic inhibitor -secretase inhibitor II (De Strooper et al., 1999; Wolfe et al., 1999).”
BackgroundH UMAN N EURODEGENERATIVE D ISEASE M ODELING U SING D ROSOPHILA
Bonini, N. M., & Fortini, M. E. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131425 · Cited by 163
Intramembrane proteolysis by presenilins
Steiner, H., & Haass, C. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043065 · Cited by 161
The physiology of the β‐amyloid precursor protein intracellular domain AICD
Pardossi‐Piquard, R., & Checler, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07475.x · Cited by 159
“This formation was prevented by the PS-directed inhibitors DFK167 (Sato et al. 2003) and L685,458 (Wolfe et al. 1999a; Qi-Takahara et al. 2005) and by PS deficiency (Weidemann et al. 2002).”
Xie, S.-S., Wang, X.-B., Li, J.-Y., Yang, L., & Kong, L.-Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.051 · Cited by 159
Duan, L., Bhattacharyya, B. J., Belmadani, A., Pan, L., Miller, R. J., & Kessler, J. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-3 · Cited by 159
“Such an Aβ rise at sub-threshold concentrations of γ-secretase inhibitors has been described in cell culture [47,48] and in vivo in human [49].”
BackgroundAssembly, Trafficking and Function of γ-Secretase
Kaether, C., Haass, C., & Steiner, H. (2006) · Neurodegenerative Diseases · doi:10.1159/000095267 · Cited by 129
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
Farmery, M. R., Tjernberg, L. O., Pursglove, S. E., Bergman, A., Winblad, B. G., & Näslund, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211992200 · Cited by 165
Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M. G., Baumeister, R., & Haass, C. (2000) · Nature Cell Biology · doi:10.1038/35008626 · Cited by 166
THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
Selkoe, D. J. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70232-2 · Cited by 162
Self-citationPresenilin function and γ‐secretase activity
Brunkan, A. L., & Goate, A. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03099.x · Cited by 145
Inhibition and Modulation of γ-Secretase for Alzheimer's Disease
Wolfe, M. S. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.010 · Cited by 143
Self-citationγ‐Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila
Micchelli, C. A., Esler, W. P., Kimberly, W. T., Jack, C., Berezovska, O., Kornilova, A., Hyman, B. T., Perrimon, N., & Wolfe, M. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0394fje · Cited by 142
Self-citationPresenilins: molecular switches between proteolysis and signal transduction
Annaert, W. G., & Strooper, B. D. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01455-1 · Cited by 158
Tian, G., Sobotka‐Briner, C. D., Zysk, J. R., Liu, X. F., Birr, C., Sylvester, M. A., Edwards, P. D., Scott, C. D., & Greenberg, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112328200 · Cited by 149
Alzheimer’s disease and Notch signaling
Woo, H., Park, J. S., Gwon, A., Arumugam, T. V., & Jo, D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.093 · Cited by 148
Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01223-7 · Cited by 137
Self-citationPotential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Liccardo, D., Marzano, F., Carraturo, F., Guida, M., Femminella, G. D., Bencivenga, L., Agrimi, J., Addonizio, A., Melino, I., Valletta, A., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00683 · Cited by 156
“…enzyme 1 (BACE1), and presenilin-containing γ-secretase (PS/γ-secretase) multi-subunit complex are involved in the generation of AβP (De Strooper et al., 1998; Struhl and Greenwald, 1999; Wolfe et al., 1999; Gu et al., 2001; De Strooper et al., 2012; Ben Halima et al., 2016; Andrew et al., 2016).”
Backgroundγ‐Secretase inhibitors and modulators for Alzheimer’s disease
Wolfe, M. S. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07501.x · Cited by 134
Self-citationXia, W., Ray, W. J., Ostaszewski, B. L., Rahmati, T., Kimberly, W. T., Wolfe, M. S., Zhang, J., Goate, A., & Selkoe, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9299 · Cited by 150
Self-citationThe Role of Presenilins in γ-Secretase Activity
Wolfe, M. S., & Haass, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000026200 · Cited by 132
Self-citationTargeting Presenilin-type Aspartic Protease Signal Peptide Peptidase with γ-Secretase Inhibitors
Weihofen, A., Lemberg, M. K., Friedmann, E., Rueeger, H., Schmitz, A., Paganetti, P., Rovelli, G., & Martoglio, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301372200 · Cited by 126
Wiltfang, J., Esselmann, H., Cupers, P., Neumann, M., Kretzschmar, H., Beyermann, M., Schleuder, D., Jahn, H., Rüther, E., Kornhuber, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102790200 · Cited by 126
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Aspartic Peptidase Inhibitors: Implications in Drug Development
Dash, C., Kulkarni, A., Dunn, B. M., & Rao, M. (2003) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/713609213 · Cited by 152
“Cathepsin D or a similar aspartic peptidase is also thought to be involved in formation of the β-amyloid peptide in Alzheimer’s disease (Papassotiropoulos et al., 1999; Wolfe et al., 1999).”
BackgroundWolfe, M. S. (2009) · Chemical Reviews · doi:10.1021/cr8004197 · Cited by 132
Self-citationStructure and Function of the γ-Secretase Complex
Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00401 · Cited by 116
Self-citationAlzheimer's disease: β‐Amyloid protein and tau
Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 116
“They further showed that mutations of two conservative Asp in TM6 and TM7 of PS (Asp-257 and Asp-385 for PS1, respectively) led to a marked reduction in A production and an accumulation of APP CTFs, as had been observed in the PSdeficient cells (Wolfe et al., 1999a).”
BackgroundResultCell‐free assays for γ‐secretase activity
McLendon, C., Xin, T., Ziani-Cherif, C., Murphy, M. P., Findlay, K. A., Lewis, P. A., Pinnix, I., Sambamurti, K., Wang, R., Fauq, A., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0286fje · Cited by 107
Kreft, A. F., Martone, R., & Porte, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900188z · Cited by 104
Evin, G. M., Sernee, M. F., & Masters, C. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00002 · Cited by 119
The germline in C. elegans: Origins, proliferation, and silencing
Seydoux, G., & Schedl, T. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)03006-6 · Cited by 121
Differential Effects of Inhibitors on the γ-Secretase Complex
Kornilova, A. Y., Das, C., & Wolfe, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300019200 · Cited by 109
Self-citationA Sensitive and Quantitative Assay for Measuring Cleavage of Presenilin Substrates
Karlström, H., Bergman, A., Lendahl, U., Näslund, J., & Lundkvist, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100649200 · Cited by 105
Identity and function of γ‐secretase
Kimberly, W. T., & Wolfe, M. S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10736 · Cited by 102
“E-mail: mwolfe@rics.bwh.harvard.edu Received 2 March 2003; Revised 23 May 2003; Accepted 23 May 2003 © 2003 Wiley-Liss, Inc. signed to inhibit A production (Wolfe et al., 1999a); however, PS1 and its close homolog PS2 lack any protease motif recognized previously.”
BackgroundSelf-citationPeptidase inhibitors in the MEROPS database
Rawlings, N. D. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.013 · Cited by 114
“001) [414]”
Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase Activities
Murphy, M. P., Uljon, S. N., Fraser, P. E., Fauq, A., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002812200 · Cited by 97
Secretases as targets for the treatment of Alzheimer's disease: the prospects
Dewachter, I., & LEUVEN, F. V. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00188-6 · Cited by 102
Alshehri, B., D’Souza, D. G., Lee, J. Y., Petratos, S., & Richardson, S. J. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12271 · Cited by 107
Martoglio, B., & Golde, T. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg303 · Cited by 98
Heilig, E. A., Xia, W., Shen, J., & Kelleher, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116962 · Cited by 105
Self-citationSteiner, H., Revesz, T., Neumann, M., Romig, H., Grim, M. G., Pesold, B., Kretzschmar, H. A., Hardy, J., Holton, J. L., Baumeister, R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007183200 · Cited by 85
γ-Secretase in biology and medicine
Wolfe, M. S. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.12.011 · Cited by 96
Self-citationLandman, N., & Kim, T. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.001 · Cited by 92
Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch
Kulic, L., Walter, J., Multhaup, G., Teplow, D. B., Baumeister, R., Romig, H., Capell, A., Steiner, H., & Haass, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100049897 · Cited by 85
Generation of C‐terminally truncated amyloid‐β peptides is dependent on γ‐secretase activity
Beher, D., Wrigley, J. D. J., Owens, A. P., & Shearman, M. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00985.x · Cited by 83
γ-Secretase as a Target for Alzheimer’s Disease
Wolfe, M. S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00004-0 · Cited by 96
Self-citationγ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
Xu, X. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0957 · Cited by 84
“Evidence suggests that the A β PP transmembrane domain is in an α -helical conformation [56,93].”
Intramembrane proteolysis by presenilin and presenilin-like proteases
Xia, W., & Wolfe, M. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00651 · Cited by 82
Self-citationNyborg, A. C., Kornilova, A. Y., Jansen, K. R., Ladd, T. B., Wolfe, M. S., & Golde, T. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309305200 · Cited by 84
Self-citation
Metadata
- Authors
- Wolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O., & Selkoe, D. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Wolfe, Michael S.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-03-26
- Volume
- 38
- Issue
- 15
- Pages
- 4720-4727
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2004305803
- Cited by
- 289
- References
- 12
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 2 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 5
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ns037537-02)
- National Institute on Aging (AG 12749, R01AG012749)
- National Heart, Lung, and Blood Institute (HL 3536)
- National Institute of Neurological Disorders and Stroke (NS37537)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- gamma-secretase, Alzheimer's disease, amyloid-beta, aspartic protease, intramembrane cleavage, amyloid precursor protein, cathepsin D, calpain, transmembrane helices, enzyme inhibition
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Humans, Hydrolysis, Ketones, Models, Molecular, Molecular Sequence Data, Endopeptidases, Protease Inhibitors, Protein Binding, Molecular Probes, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Molecular Mimicry, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.